Login to Your Account

FDA Pitches Soft Ball with Gattex Briefing Docs in SBS

By Catherine Shaffer
Staff Writer

Friday, October 12, 2012
Briefing documents that were released ahead of the Gastrointestinal Drugs Advisory Committee (GIDAC) meeting for short bowel drug Gattex (teduglutide) held "no surprises" according the drugmaker, NPS Pharmaceuticals Inc.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription